治疗中度至重度亚托皮炎的新型治疗方法 婴儿多价过敏敏感化多价过敏敏感化
1Department of Allergology, National Medical Institute of the Ministry of the Interior and Administration, 02-507, 137 Woloska Str., Warsaw, Poland.
Journal of mother and child
|February 13, 2026
概括
一种新的联合疗法通过减少症状和过敏反应,显著改善了婴儿中等至重症湿疹. 这种方法还使肠道微生物群正常化,为具有多种过敏敏感性的亚托皮炎提供了优越的治疗方法.
科学领域:
- 儿科皮肤病学 儿科皮肤病学
- 免疫学 免疫学 免疫学
- 微生物组研究 微生物组研究
背景情况:
- 患有中度至重度湿疹的婴儿通常具有多价过敏敏感性,使治疗复杂化.
- 像软化剂和抗组胺剂这样的标准疗法在这些情况下显示出有限的疗效.
研究的目的:
- 评估婴儿中等至重症湿疹和多价过敏敏感化的综合治疗方法的治疗疗效.
主要方法:
- 一项涉及87名婴儿 (3-12个月) 的随机对照试验比较了联合治疗 (伪胺,氨酸抑制剂,口服协生药) 与标准治疗.
- 评估的结果包括SCORAD指数, (VAS),POEM得分,睡眠,易怒,免疫标记 (IgE,IL-4,IL-13) 和肠道微生物群组成.
主要成果:
- 组合治疗组在SCORAD (>60%), (2.7倍) 和POEM得分 (61%) 中显著降低,睡眠和行为改善.
- 免疫学标志物表明了Th2反应的抑制 (降低IgE,IL-4,IL-13).
- 肠道微生物群分析显示,Bifidobacterium spp.增加,α多样性更高,大肠杆菌减少,这表明微生物平衡恢复.
结论:
- 结合疗法显示出明显优于标准治疗的婴儿与亚托皮炎和多种过敏敏感的婴儿.
- 治疗有效改善了临床症状,抑制了Th2介导的免疫反应,并使肠道微生物群正常化.
相关概念视频
Allergic Reactions
32.5K
Overview
32.5K
Allergic Reactions: Anaphylaxis
18
Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin,...
18
Allergic Drug Reactions
1.5K
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.5K
Drug Toxicity: Allergic Reactions
16
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial...
16
Therapeutic Index
7.0K
The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
7.0K
Drug Dosing: Infants and Children
335
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
335


